Early stopping rules employing early progression and response compared with conventional stopping rules in actual phase II trials. Background: The high-affinity folate receptor alpha is selectively ...
The U.S. Food and Drug Administration is considering approval of the drug leucovorin to treat children with cerebral folate deficiency and symptoms of autism. Kevin Pelphrey is the Harrison-Wood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results